Investor Overview


Investor Overview

Webcast
Q1 2021 Xenon Pharmaceuticals Inc. Earnings Conference Call
May 11, 2021 at 4:30 pm EDT

Company Profile


We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. Our novel product pipeline of neurology therapies addresses areas of high unmet medical need, with a focus on epilepsy.

Data Provided by Refinitiv. Minimum 15 minutes delayed.